Company intelligence
uMotif
About uMotif
Putting patients first is in uMotif’s DNA. The modern uMotif eCOA platform delivers faster, high-quality clinical trials and real-world studies by putting patients at the core of research. Combined with uMotif’s robust site tools – including consent management, site productivity, and trial awareness – the platform strengthens the patient-site relationship, which is key to improving eCOA compliance and retention. With cloud hosting in the US, Europe, and China, the GCP, 21 CFR Part 11 and GDPR-compliant platform supports all study phases and indications. Visit www.umotif.com
Verified activity
Signals from uMotif
3 published signals
Presence & Recognition
uMotif is attending the EEC in Athens next week to share perspectives on improving eCOA data quality.
Reported by Michael McGloughlin
Presence & Recognition
uMotif team is heading to the European Epilepsy Congress this weekend.
Reported by Bruce Hellman
Legal & Regulatory
uMotif reported that Meta removed Facebook and Instagram ads that promoted malicious Android apps and adult content to steal banking details.
Reported by Buraq Alsmadi 🍉